Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.83
+10.24%
Mkt Cap $443.84M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
Implied Upside
+251.4%
Consensus $6.43 vs current $1.83
NASDAQ·Healthcare·Biotechnology
$1.83
+10.24%
Mkt Cap $443.84M
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
+251.4%
Consensus $6.43 vs current $1.83